Abstract
The apoptotic protease activating factor (Apaf-1) plays a central role in apoptosis: interaction of this protein with procaspase-9 leads to cleavage and activation of this initiator caspase. In common with other mRNAs whose protein products have a major regulatory function, the 5′ untranslated region (UTR) of Apaf-1 is long, G-C rich and has the potential to form secondary structure. We have shown that the 5′ UTR of Apaf-1 contains an internal ribosome entry segment, located in a 233 nucleotide region towards the 3′ end of the leader, and that the translation initiation of this mRNA occurs only by internal ribosome entry. The Apaf-1 IRES is active in almost all human cell types tested, including Human cervical carcinoma (HeLa), Human liver carcinoma (HepG2), Human breast carcinoma (MCF7), Human embryonic kidney (HK293), African Green Monkey kidney (COS7) and Human lung (MRC5). The Apaf-1 IRES initiates translation as efficiently as the HRV IRES, but is less active than the c-myc IRES. We propose that the Apaf-1 IRES ensures that a constant cellular level of Apaf-1 protein is maintained even under conditions where cap-dependent translation is compromised.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- IRES:
-
internal ribosome entry segment
- UTR:
-
untranslated region
- Apaf-1:
-
Apoptotic protease activating factor-1
- eIF:
-
eukaryotic initiation factor
References
Adams JM and Cory S. . 1998 Science 281: 1322–1326.
Bernstein J, Sella O, Le S and Elroy-Stein O. . 1997 J. Biol. Chem. 272: 9356–9362.
Bonneau AM and Sonenberg N. . 1987 J. Biol. Chem. 262: 11134–11139.
Burgess DH, Svensson M, Dandrea T, Gronlund K, Hammarquist F, Orrenius S and Cotgreave IA. . 1999 Cell Death Differ. 6: 256–261.
Cardozo TJ and Abagyan R. . 1998 J. Mol. Modelling 4: 83–93.
Cecconi F, Alvarez-Bolado G, Meyer B, Roth KA and Gruss P. . 1998 Cell 94: 727–737.
Clemens MJ, Bushell M and Morley S. . 1998 Oncogene 17: 2921–2931.
Cohen GM. . 1997 Biochem. J. 326: 1–16.
Cryns V and Yuan J. . 1998 Genes Dev. 12: 1551–1570.
De Benedetti A, Joshi B, Graff JR and Zimmer SG. . 1994 Mol. Cell. Differ. 2: 347–371.
De Benedetti A and Rhoads RE. . 1990 Proc. Natl. Acad. Sci. USA 87: 8212–8216.
Holcik M, Lefebvre C, Yeh C, Chow T and Korneluk RG. . 1999 Nature Cell Biol. 1: 190–192.
Horvitz HR, Shaham S and Hengartner MO. . 1994 Cold Spring Harbor Symposia in Quantitative Biology 59: 377–385.
Hu Y, Benedict MA, Wu D, Inohara N and Nunez G. . 1998a Proc. Natl. Acad. Sci. USA 95: 4386–4391.
Hu Y, Ding L, Spencer DM and Nunez G. . 1998b J. Biol. Chem. 273: 33489–33494.
Jackson RJ, Hunt SL, Gibbs CL and Kaminski A. . 1994 Mol. Biol. Reports 19: 147–159.
Jackson RJ, Hunt SL, Reynolds JE and Kaminski A. . 1995 Curr. Top. Microbiol. Immunol. 203: 1–29.
Jackson RJ and Kaminski A. . 1995 RNA 1: 985–1000.
Jacobson MD, Weil M and Raff MC. . 1997 Cell 88: 347–354.
Johannes G and Sarnow P. . 1998 RNA 4: 1500–1513.
Jordan M, Schallhorn A and Wurm FM. . 1996 Nucleic Acids Res. 24: 596–601.
Kevil C, Carter P, Hu B and DeBenedetti A. . 1995 Oncogene 11: 2339–2348.
Lamphear BJ, Kirchweger R, Skern T and Rhoads RE. . 1995 J. Biol. Chem. 270: 21975–21983.
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X. . 1997 Cell 91: 479–489.
Marissen W and Lloyd RE. . 1998 Mol. Cell. Biol. 18: 7565–7574.
Miller D, Dibbens J, Damert A, Risau W, Vadas M and Goodall G. . 1998 FEBS Lett. 434: 417–420.
Morley SJ, McKendrick L and Bushell M. . 1998 FEBS Lett. 438: 41–48.
Nanbru C, Lafon I, Audiger S, Gensac G, Vagner S, Huez G and Prats A-C. . 1997 J. Biol. Chem. 272: 32061–32066.
Nunez G, Benedict MA, Hu Y and Inohara N. . 1998 Oncogene 17: 3237–3245.
Ohlmann T, Rau M, Pain VM and Morley SJ. . 1996 EMBO J. 15: 1371–1382.
Pain VM. . 1996 Eur J Biochem 236: 747–771.
Pan G, O'Rourke K and Dixit VM. . 1998 J. Biol. Chem 273: 5841–5845.
Panniers R. . 1994 Biochimie 76: 737–747.
Perkins C, Kim CN, Fang GF and Bhalla KN. . 1998 Cancer Res. 58: 4561–4566.
Pestova T, Shatsky IN and Hellen UT. . 1996 Mol. Cell Biol. 16: 6870–6878.
Reed JC, Jurgensmeier JM and Matsuyama S. . 1998 Biochimica et Biophysica Acta 1366: 127–137.
Rhoads RE and Lamphear BJ. . 1995 Curr. Top. Microbiol. Immunol. 203: 131–153.
Saleh A, Srinivasula SM, Acharya S, Fishel R and Alnemri ES. . 1999 J. Biol. Chem. 274: 17941–17945.
Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW and Lowe SW. . 1999 Science 284: 156–159.
Stein I, Itin A, Einat P, Skaliter R, Grossman Z and Keshet E. . 1998 Mol. Cell. Biol. 18: 3112–3119.
Stoneley M, Paulin FEM, Le Quesne JPC, Chappell SA and Willis AE. . 1998 Oncogene 16: 423–428.
Stoneley M. . 1998 Functional Analysis of the 5′ untranslated region of the c-myc proto-oncogene PhD Thesis University of Leicester.
Stoneley M, Chappell SA, Jopling CL, Dickens M, MacFarlane M and Willis AE. . 2000 Mol. Cell. Biol. 20: In press.
Vagner S, Gensac M-C, Maret A, Bayard F, Amalric F, Prats H and Prats A-C. . 1995 Mol. Cell. Biol. 15: 35–44.
West MJ, Stoneley M and Willis AE. . 1998 Oncogene 17: 769–780.
West MJ, Sullivan NF and Willis AE. . 1995 Oncogene 13: 2515–2524.
Yang G and Sarnow P. . 1997 Nucleic Acids Res. 25: 2800–2807.
Yoshida H, Kong Y-Y, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM and Mak TW. . 1998 Cell 94: 739–750.
Zamora AJ, Tessier F, Marconnet P, Margaritis I and Marini JF. . 1995 Eur. J. App. Physiol. 71: 505–511.
Zou H, Henzel WJ, Liu X, Lutschg A and Wang X. . 1997 Cell 90: 405–413.
Zou H, Li Y, Liu X and Wang X. . 1999 J. Biol. Chem. 274: 11549–11556.
Acknowledgements
This work was supported by a grant from the Wellcome Trust number 055580 (SA Mitchell). MJ Coldwell holds an MRC studentship.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coldwell, M., Mitchell, S., Stoneley, M. et al. Initiation of Apaf-1 translation by internal ribosome entry. Oncogene 19, 899–905 (2000). https://doi.org/10.1038/sj.onc.1203407
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203407
Keywords
This article is cited by
-
Translation machinery reprogramming in programmed cell death in Saccharomyces cerevisiae
Cell Death Discovery (2021)
-
The role of CSDE1 in translational reprogramming and human diseases
Cell Communication and Signaling (2020)
-
DAP5 increases axonal outgrowth of hippocampal neurons by enhancing the cap-independent translation of DSCR1.4 mRNA
Cell Death & Disease (2019)
-
Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cells
Cell Death & Disease (2017)
-
Translational control of PML contributes to TNFα-induced apoptosis of MCF7 breast cancer cells and decreased angiogenesis in HUVECs
Cell Death & Differentiation (2016)